Development of Sandwich ELISA for Detecting Serum Programmed Cell Death 5 and Its Clinical Application

WANG Yun-long,ZHAO Su-hua,CHEN Ying-yu,LI Yu-lin,LIU Wang-gen,WANG Ji-chuang,WANG Guo-qiang,SUN Xin-cheng,DONG Cai-wen,CHENG Lei,LI Heng-si

DOI: https://doi.org/10.3969/j.issn.1007-5038.2012.04.005

2012-01-01

Abstract:To establish an enzyme-linked immunosorbent assay(ELISA)method to detect PDCD5 in human serum and evaluate the relitationships between patients and their PDCD5 quantity in blood,the microplate was precoated with anti-PDCD5 PcAb,and PDCD5 McAb linked with enzyme HRP to catalize substrates.The recombinant PDCD5 protein was used as standard,and the standard curve was established.Thus the sandwich ELISA method was developed for detecting PDCD5 in human serum quantitatively.After evaluating ELISA method in specificity,sensitivity and stability,the method was applied in detecting serum PDCD5 in 81 patients of cancer,and 21 patients of rheumatoid arthritis,then the relationship between serum PDCD5 levels and cancer,rheumatoid arthritis was evaluated.The results showedthe double diffusion assay confirmed the enzyme and antibody had the biological activity.And a quantitative ELISA method for detecting PDCD5 in human serum was successfully set up.The sensitivity of this medthod reached 0.5 ng/mL,the accuracy and reproducibility were good.Our results showed the concentration of serum PDCD5 was significantly higher in immunocompromised patients serum than in normal serum(P0.01);The concentration of serum PDCD5 was significantly lower in cancer patients serum than in normal serum(P0.05).There was no significant difference among several cancer patients.A rapid and simple quantitative ELISA method for detecting PDCD5 in human serum was established.And Provide reference value for clinical diagnosis of disease.